Bicycle Therapeutics

company

About

Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.

  • 101 - 250

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$50M
Industries
Biotechnology,Medical Device,Therapeutics
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$161.90M
Bicycle Therapeutics has raised a total of $161.90M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2020 Debt Financing $50M 1 Detail
Dec 1, 2018 Series B $27.90M 1 Detail
Jun 1, 2017 Series B $52M 1 Detail
Oct 14, 2014 Series A $32M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Bicycle Therapeutics is funded by 3 investors. Hercules Capital and Cambridge Innovation Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Debt Financing
Cambridge Innovation Capital Series B
Syndicate Series A